WallStreetZenWallStreetZen

NASDAQ: ATPC
Agape Atp Corp Stock

$0.22-0.02 (-8.33%)
Updated Apr 26, 2024
ATPC Price
$0.22
Fair Value Price
N/A
Market Cap
$17.01M
52 Week Low
$0.21
52 Week High
$3.75
P/E
-7.37x
P/B
3.89x
P/S
33.85x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.43M
Earnings
-$2.10M
Gross Margin
65.4%
Operating Margin
-146.63%
Profit Margin
-146.9%
Debt to Equity
0.31
Operating Cash Flow
-$2M
Beta
0.93
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ATPC Overview

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. The company offers three series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, and BEAUNIQUE names. Its products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP2 Energized Mineral Concentrate, a nutritional supplement, which supports and enhances nutritional biochemical activities; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1 Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. The company also provides BEAUNIQUE Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and ORYC-Organic Youth Care Cleansing Bar, an organic cleansing soap for the skin. In addition, it offers N°1 Med-Hydration, a mask that enhances skin moisture and luminosity; N°2 Med-Whitening, a mask for boosting skin moisture level and protecting skin against UV radiation; N°3 Med-Firming, which provides protection and maintenance of the basal skin collagen production; ÉNERGÉTIQUE hyaluronic acid serum; and ÉNERGÉTIQUE mousse facial cleanser, as well as Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. Further, the company engages in wholesaling of health and wellness products; and wellness and wellbeing lifestyle promotion services, as well as provision of complementary health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Zen Score

–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATPC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ATPC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ATPC is poor value based on its book value relative to its share price (3.89x), compared to the US Health Information Services industry average (3.38x)
P/B vs Industry Valuation
ATPC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ATPC due diligence checks available for Premium users.

Be the first to know about important ATPC news, forecast changes, insider trades & much more!

ATPC News

Valuation

ATPC fair value

Fair Value of ATPC stock based on Discounted Cash Flow (DCF)
Price
$0.22
Fair Value
-$0.69
Undervalued by
131.72%
ATPC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ATPC price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-7.37x
Industry
72.49x
Market
41.14x

ATPC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
3.89x
Industry
3.38x
ATPC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ATPC's financial health

Profit margin

Revenue
$391.1k
Net Income
-$974.4k
Profit Margin
-249.2%
ATPC's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ATPC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$5.7M
Liabilities
$1.4M
Debt to equity
0.31
ATPC's short-term assets ($5.19M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ATPC's short-term assets ($5.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ATPC's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ATPC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.0M
Investing
-$10.1k
Financing
$5.5M
ATPC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ATPC vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
ATPC$17.01M-8.30%-7.37x3.89x
CCLD$17.41M+1.89%-0.26x0.42x
ETAO$15.86M+1.52%-0.02x-1.02x
STRM$18.88M-5.59%-0.94x0.96x
AKLI$19.23M+0.82%-0.32x0.33x

Agape Atp Stock FAQ

What is Agape Atp's quote symbol?

(NASDAQ: ATPC) Agape Atp trades on the NASDAQ under the ticker symbol ATPC. Agape Atp stock quotes can also be displayed as NASDAQ: ATPC.

If you're new to stock investing, here's how to buy Agape Atp stock.

What is the 52 week high and low for Agape Atp (NASDAQ: ATPC)?

(NASDAQ: ATPC) Agape Atp's 52-week high was $3.75, and its 52-week low was $0.21. It is currently -94.11% from its 52-week high and 5.24% from its 52-week low.

How much is Agape Atp's stock price per share?

(NASDAQ: ATPC) Agape Atp stock price per share is $0.22 today (as of Apr 26, 2024).

What is Agape Atp's Market Cap?

(NASDAQ: ATPC) Agape Atp's market cap is $17.01M, as of Apr 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Agape Atp's market cap is calculated by multiplying ATPC's current stock price of $0.22 by ATPC's total outstanding shares of 76,966,712.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.